Cytoxan (Cyclophosphamide)

£0.00

Cytoxan (cyclophosphamide) is a chemotherapy medicine used to treat certain cancers and some immune-related conditions. It works by slowing or stopping the growth of fast-growing cells. It may be given as an infusion or by mouth, depending on your treatment plan. Your care team will check your blood counts and watch for side effects such as infection risk, nausea, tiredness, and bladder irritation. Tell them about any unusual bleeding or fever.

Cytoxan (Cyclophosphamide) — Patient Guide (UK)

Cytoxan is a chemotherapy medicine containing cyclophosphamide. It is used to treat a range of cancers and some serious autoimmune conditions. Because cyclophosphamide can affect blood cells, the immune system and other organs, its use requires careful monitoring by specialist healthcare teams.

This guide explains how Cytoxan works, how the body handles it, typical uses, timing considerations, food and medicine interactions, safety information, and practical tips—written for patients in the United Kingdom.


Basic product information

Category Details
Medicine Cytoxan
Active ingredient Cyclophosphamide
Medicinal form Often available as tablets and/or injection preparations (presentation varies by manufacturer and treatment plan)
Type of medicine Chemotherapy agent (alkylating agent) with immunosuppressive effects
Common clinical settings Oncology and specialist rheumatology/autoimmune services

Important: Your exact dose and schedule depend on your condition, treatment regimen, blood counts, kidney/liver function, and other medicines you take.


How Cytoxan works (mechanism of action)

Cyclophosphamide is a prodrug. This means it is not fully active when swallowed or injected. After absorption, it is converted by enzymes mainly in the liver into active metabolites.

Its main actions include:

  • Alkylation of DNA: Active metabolites attach to DNA strands, damaging them.
  • Prevents cell division: DNA damage interferes with replication, particularly in fast-growing cells.
  • Immune suppression (in some conditions): By affecting rapidly dividing immune cells, it can reduce abnormal immune activity.

Because it targets DNA and rapidly dividing cells, it can affect both cancer cells and some healthy tissues, which is why monitoring and supportive care are essential.


Pharmacokinetics (what the body does to the medicine)

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine.

Absorption

When taken by mouth, cyclophosphamide is absorbed and then metabolised. Bioavailability can vary between individuals, and food can affect the speed and extent of absorption in some circumstances.

Distribution

After activation, metabolites distribute through the body and can reach tissues relevant to treatment.

Metabolism

Cyclophosphamide is metabolised primarily in the liver via enzymes that include the CYP450 system. The pattern and rate of metabolism can change with other medicines and with liver function.

Elimination

Metabolites are removed mainly through the kidneys and excreted in urine. This matters for safety, because cyclophosphamide metabolites can irritate the bladder in some people.

Monitoring-related implication: Kidney function, urine output, and blood counts influence dosing decisions and supportive measures.


Typical uses in the UK

Cyclophosphamide is used in specialist pathways. The exact use depends on whether the goal is cancer treatment or disease control in certain autoimmune disorders.

Common cancer indications (examples)

  • Lymphomas (often in combination regimens)
  • Leukaemias (as part of multi-drug chemotherapy plans)
  • Multiple myeloma (in some older or specific regimen choices)
  • Some solid tumours where cyclophosphamide is part of combination therapy

Autoimmune and inflammatory conditions (examples)

In selected cases, cyclophosphamide may be used for severe autoimmune diseases where other treatments are insufficient. Examples can include:

  • Severe vasculitis (specialist-led)
  • Certain serious inflammatory lung conditions (specialist-led)
  • Other life-threatening autoimmune scenarios where benefits outweigh risks

Note: Not all patients with autoimmune disease are suitable. Decisions depend on disease severity, organ involvement, and the risk/benefit balance.


Timing and how to take Cytoxan

The timing and schedule vary widely depending on the regimen. Follow the treatment plan provided by your clinical team and the instructions on your medicine label.

Typical practical timing points

  • Try to take doses at consistent times each day if your regimen is daily.
  • On cyclical schedules (e.g., weekly or every few weeks), timing is based on your cycle day(s).
  • Blood tests are usually required before and during treatment to check blood counts and organ function.

If you miss a dose

Do not double doses. Contact your specialist team or pharmacy for advice specific to your schedule.


Food interactions

Food can influence the absorption of oral cyclophosphamide in some people. To keep treatment consistent:

  • Eat and drink normally, but try to be consistent with meal timing if your clinician has advised it.
  • Avoid sudden major changes in diet unless advised, especially if nausea or absorption concerns occur.

General advice: If you get nausea, your healthcare team may recommend anti-sickness medicines (antiemetics) or timing adjustments.


Alcohol and medicine interactions

Alcohol

Because cyclophosphamide can affect liver function and can be part of intensive care, it’s generally recommended to avoid or minimise alcohol unless your clinician says otherwise. Alcohol may also worsen nausea, fatigue and dehydration—factors that can indirectly affect safety (especially if you are advised to maintain good hydration).

Important medicine interactions

Cyclophosphamide is metabolised in the liver and interacts with other drugs that influence liver enzymes or bone marrow function. Always tell your doctor and pharmacist about all medicines and supplements you use, including:

  • Other chemotherapy agents (increased risk of low blood counts)
  • Medicines that suppress the immune system (higher infection risk)
  • Drugs affecting CYP enzymes (e.g., certain antifungals, antivirals, antibiotics, antidepressants, anticonvulsants)
  • Warfarin and other anticoagulants (blood count changes and liver effects can influence bleeding risk)
  • Drugs that affect kidney function (may change clearance)
  • Herbal products (some can influence liver enzymes)

Do not start or stop medicines without checking first. Your oncology or specialist team can check interaction risk quickly.


Dosing information (general guidance)

Dosing is individualised. Cyclophosphamide dosing depends on:

  • Diagnosis and treatment goal
  • Body surface area (commonly used in chemotherapy)
  • Kidney and liver function
  • Blood counts (neutrophils, platelets, haemoglobin)
  • Whether used alone or in combination
  • Previous treatment and cumulative exposure

Typical regimen patterns include cyclical schedules (e.g., daily for a period then rest days) or intermittent dosing. For many cancer treatments, it is combined with other medicines and supportive therapies.

Key safety point: It’s essential to follow the dose precisely. Incorrect dosing can increase toxicity or reduce effectiveness.


Safety profile and side effects

Cytoxan can cause a range of side effects. Some are expected and manageable; others require urgent medical attention. Your clinical team will monitor you closely.

Commonly monitored safety risks

  • Bone marrow suppression (low white blood cells, anaemia, low platelets)
  • Infection risk due to reduced immune defence
  • Bladder irritation and in some cases bleeding (haemorrhagic cystitis)
  • Nausea and vomiting
  • Hair thinning or hair loss
  • Fatigue
  • Infertility risk and potential effects on sexual health
  • Potential effects on fertility and unborn babies

When to seek urgent help

Contact your urgent care service or your clinical team immediately if you experience:

  • Fever or signs of infection (especially if you have low neutrophils)
  • Severe shortness of breath or chest pain
  • Blood in urine, painful urination, or inability to pass urine
  • Uncontrolled vomiting or signs of severe dehydration
  • Unusual bleeding or bruising
  • Severe allergic reaction symptoms (e.g., swelling of face/lips, rash with breathing difficulty)

Fertility, pregnancy and contraception

Cyclophosphamide can affect fertility in men and women. It may also cause harm to a developing baby.

  • Women: pregnancy should be avoided during treatment; discuss reliable contraception and family planning with your specialist team.
  • Men: consider sperm preservation options before treatment; use effective contraception as advised.

Long-term considerations

Cumulative exposure to chemotherapy agents can be associated with risks such as secondary cancers in some cases, and can affect heart function depending on overall regimen. Your clinician can discuss individual risk factors and what monitoring is needed.


Practical use tips (safe day-to-day guidance)

These tips can help reduce avoidable risks and support tolerability. Always follow the specific advice from your healthcare team.

Hydration and bladder protection

  • Drink fluids as advised by your team (often encouraged during treatment).
  • Report painful urination or blood in urine promptly.
  • Your specialist team may prescribe protective measures (for example, medicines or hydration protocols) to reduce bladder irritation risk.

Preventing infection

  • Practice good hand hygiene.
  • Avoid close contact with people who have contagious infections.
  • Keep up with scheduled blood tests—your team may delay treatment or adjust supportive medication based on results.

Nausea management

  • Take anti-sickness medicines exactly as directed.
  • Small frequent meals may be easier than large meals.
  • Tell your team if nausea is not controlled—there are often alternative strategies.

Blood count support

Your team may use supportive treatments (for example, growth factors) depending on your risk of neutropenia. Do not self-start additional medicines without advice.

Protect yourself and others from body fluids

Cyclophosphamide can be present in body fluids during treatment. Follow your hospital or pharmacy instructions for handling hygiene waste safely (for example, careful handling of body fluids and cleaning). Your team will provide guidance appropriate to your regimen.

Driving and operating machinery

Fatigue, dizziness or other side effects may affect your ability to drive or use tools. If you feel unwell, avoid driving and seek advice.


Alternative options

“Alternative” depends on your diagnosis and regimen. If cyclophosphamide is unsuitable due to side effects, interactions, or organ function, specialist teams may consider:

  • Other chemotherapy agents with different mechanisms (for cancers)
  • Different immunosuppressive medicines (for autoimmune diseases), such as other disease-modifying therapies
  • Targeted therapies or monoclonal antibodies where appropriate
  • Radiotherapy or surgery as part of cancer care plans

Your oncologist or specialist doctor can explain the available options for your specific condition, including expected benefits and risks.


UK market and legal context

In the UK, cyclophosphamide medicines are regulated and supplied under strict controls because they are high-risk and require specialist oversight. Access to Cytoxan is typically through specialist services as part of approved treatment pathways and protocols.

Key points relevant to patients in the UK:

  • Specialist supervision is required due to the need for blood tests and monitoring.
  • Controlled handling may apply in certain settings.
  • Pharmacovigilance systems support reporting of side effects and monitoring of safety information.

Your pharmacy team can explain what paperwork, monitoring schedules, and safety steps apply to your specific supply route.


Recent guidance and monitoring (UK-focused)

Guidance for chemotherapy and immunosuppression in the UK evolves based on emerging evidence and regulatory updates. Although your exact regimen follows your specialist plan, these monitoring themes are consistently emphasised:

  • Frequent full blood counts before each treatment decision and during therapy.
  • Infection risk assessment and rapid evaluation if fever develops.
  • Bladder protection and hydration protocols where appropriate.
  • Fertility and pregnancy counselling before starting therapy.
  • Medication interaction checks at each review.

If you are unsure about any monitoring schedule (blood tests, urine checks, symptom monitoring), ask your specialist team or pharmacist.


Delivery and availability (UK)

Availability may vary depending on your prescribed presentation and local supply chain. In the UK, specialist medicines like cyclophosphamide can be supplied through pharmacy services aligned with clinical pathways.

Delivery considerations:

  • Some supplies may be arranged for collection or delivery around treatment appointments.
  • You may be contacted to confirm patient details and ensure the correct product and strength are supplied.
  • Ensure someone can receive the package if delivery is required.

Storage: Keep medicines as directed on the label. Check storage conditions such as temperature and protection from light. Keep out of reach of children.


FAQ

1) What is Cytoxan used for?

Cytoxan (cyclophosphamide) is used as chemotherapy for certain cancers and may also be used for selected severe autoimmune/inflammatory conditions under specialist care.

2) How long does treatment with Cytoxan usually last?

It depends on your diagnosis and regimen. Some treatments are given in cycles over weeks or months, while others follow different schedules. Your specialist team will provide a timeline based on your plan.

3) How soon will I feel side effects?

Some side effects may appear within days (such as nausea or fatigue). Other effects, like low blood counts, are typically monitored and may become apparent over the days following treatment. If you’re unsure, ask when to watch for specific symptoms.

4) Why are blood tests needed?

Cyclophosphamide can suppress bone marrow, reducing white blood cells, red blood cells and platelets. Blood tests help ensure it’s safe to continue and help guide dose adjustments or supportive therapies.

5) Can I drink alcohol while taking Cytoxan?

It’s generally advised to avoid or minimise alcohol during chemotherapy due to potential liver effects and increased risk of dehydration and side effects. Follow your clinician’s advice.

6) What should I do if I develop a fever?

Fever during treatment can be a sign of infection, which can become serious quickly. Contact your clinical team urgently or seek emergency medical help per your service instructions.

7) Does food matter?

Food may influence absorption for oral dosing. Try to follow consistent timing practices as advised and report persistent nausea or vomiting to your clinical team.

8) Will Cytoxan affect fertility?

It can. Fertility effects are possible for both women and men, and pregnancy should be avoided during treatment. Discuss fertility preservation and contraception options before starting therapy if this is relevant to you.

9) Are there alternatives to Cytoxan?

Yes, depending on your condition. Alternatives may include different chemotherapy agents, immunosuppressive treatments, targeted therapies, or other components of cancer/immune care plans. Your specialist can advise what fits your situation.

10) How should I store Cytoxan at home?

Store according to the label instructions. Keep the medicine in its original packaging if possible, in a safe place away from children and pets.


Always consult your specialist team or pharmacist if you have questions about your particular regimen, side effects, or interactions with other medicines. If you feel unwell or notice warning symptoms, seek prompt medical advice.

Additional information

Dosage: No selection

50mg

Package: No selection

30 pill, 60 pill, 90 pill, 120 pill, 180 pill, 360 pill